-transparent.png){kind=logo}
Ibudilast selectively vasodilates cerebral vessels without reducing blood pressure. We investigated the effect of the drug on retinal circulation in 8 patients with diabetes mellitus, using the video-densitometric image analysis of fluorescein angiography. We compared the build up time, the time constant of washout rate and the mean circulation time (MCT) before and after oral therapy with ibudilast. After 2 weeks of daily administration (30 mg), MCT was shortened significantly (4.2 +/- 2.8 vs. 3.0 +/- 1.6 s, p = 0.0215). Since retinal circulation in patients with diabetes mellitus was improved by ibudilast, the drug may be useful to treat disorders such as diabetic retinopathy.
R Suzuki, and
I Sugihara, and
T Ishibashi, and
S Kurimoto
January 1988,
Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft,
R Suzuki, and
I Sugihara, and
T Ishibashi, and
S Kurimoto
November 2013,
Current eye research,
R Suzuki, and
I Sugihara, and
T Ishibashi, and
S Kurimoto
December 2010,
Investigative ophthalmology & visual science,
R Suzuki, and
I Sugihara, and
T Ishibashi, and
S Kurimoto
August 1991,
The British journal of ophthalmology,
R Suzuki, and
I Sugihara, and
T Ishibashi, and
S Kurimoto
September 2017,
Drug and alcohol dependence,
R Suzuki, and
I Sugihara, and
T Ishibashi, and
S Kurimoto
July 1986,
Archives of ophthalmology (Chicago, Ill. : 1960),
R Suzuki, and
I Sugihara, and
T Ishibashi, and
S Kurimoto
January 2013,
Forschende Komplementarmedizin (2006),
R Suzuki, and
I Sugihara, and
T Ishibashi, and
S Kurimoto
July 1986,
Archives of ophthalmology (Chicago, Ill. : 1960),
R Suzuki, and
I Sugihara, and
T Ishibashi, and
S Kurimoto
April 1996,
The British journal of ophthalmology,
R Suzuki, and
I Sugihara, and
T Ishibashi, and
S Kurimoto
October 2017,
Investigative ophthalmology & visual science,
